A Bridging Study of the SYN023 on Healthy Adult Subjects

Clinical trial NCT04495569 · COMPLETED

Trial details

NCT number: NCT04495569
Sponsor: Synermore Biologics (Suzhou) Co., Ltd.
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Communicable Disease Transmission Zoonotic Disease Rabies Human Vaccine Reaction Immunisation Reaction

Start date: 2019-02-26
Primary completion: 2019-06-20
Enrollment: 33

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.